Literature DB >> 9894727

Correction of neutropenia and hypogammaglobulinemia in X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation.

P R Scholl1, M R O'Gorman, L M Pachman, P Haut, M Kletzel.   

Abstract

X-linked hyper-IgM (X-HIM) syndrome is a primary immunodeficiency disease characterized by defects in both cellular and humoral immunity. X-HIM is caused by mutations in the gene for CD40 ligand (CD40L), a T cell membrane protein that mediates T cell-dependent immune functions. We report the case of a 6-year-old male with X-HIM due to an intronic mutation resulting in aberrant CD40L RNA splicing and absence of detectable CD40L protein. The patient had a history of multiple infectious complications and chronic neutropenia requiring treatment with recombinant granulocyte colony-stimulating factor, and underwent allogeneic bone marrow transplantation from an HLA-matched sibling donor. Following successful engraftment, T cell CD40L expression and immunoglobulin isotype switching were reconstituted and neutropenia resolved. Allogeneic bone marrow transplantation can correct neutropenia and reconstitute immune function in X-HIM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9894727     DOI: 10.1038/sj.bmt.1701512

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  6 in total

Review 1.  The hyper IgM syndromes.

Authors:  Nashmia Qamar; Ramsay L Fuleihan
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

2.  Bone marrow transplantation for CD40 ligand deficiency: a single centre experience.

Authors:  K Khawaja; A R Gennery; T J Flood; M Abinun; A J Cant
Journal:  Arch Dis Child       Date:  2001-06       Impact factor: 3.791

Review 3.  The hyper IgM syndrome.

Authors:  R L Fuleihan
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

4.  CD154-CD40 interactions in the control of murine B cell hematopoiesis.

Authors:  Jennifer Carlring; Hala M Altaher; Susan Clark; Xi Chen; Sarah L Latimer; Tracey Jenner; Anne-Marie Buckle; Andrew W Heath
Journal:  J Leukoc Biol       Date:  2011-02-17       Impact factor: 4.962

5.  Hyper IgM Syndrome: a Report from the USIDNET Registry.

Authors:  Emily A Leven; Patrick Maffucci; Hans D Ochs; Paul R Scholl; Rebecca H Buckley; Ramsay L Fuleihan; Raif S Geha; Coleen K Cunningham; Francisco A Bonilla; Mary Ellen Conley; Ronald M Ferdman; Vivian Hernandez-Trujillo; Jennifer M Puck; Kathleen Sullivan; Elizabeth A Secord; Manish Ramesh; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2016-05-17       Impact factor: 8.542

6.  Elective bone marrow transplantation in a child with X-linked hyper-IgM syndrome presenting with acute respiratory distress syndrome.

Authors:  V Leone; A Tommasini; M Andolina; G Runti; U De Vonderweid; C Campello; L D Notarangelo; A Ventura
Journal:  Bone Marrow Transplant       Date:  2002-07       Impact factor: 5.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.